Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients

PURPOSE: The availability of different routes of administration of rituximab, with different dosing and times of infusion in the day care unit, raises the question of which formulation would be the best in terms of direct cost, particularly with the approval of new intravenous (IV) rituximab biosimi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinicoecon Outcomes Res
Main Authors: Delgado Sánchez, Olga, Gutiérrez, Antonio, do Pazo, Fernando, Ginés, Jordi, Martorell, Clara, Boyeras, Bàrbara, Bento, Leyre, Garcia-Recio, Marta, Sampol, Antonia
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6874115/
https://ncbi.nlm.nih.gov/pubmed/31819561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S212257
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados